Table 3 Mean number of anti-VEGF injections used in each group

Total number of intravitreal injections (n, SD)

6.26 (SD 1.06)

10.05 (SD 1.06)

13.09 (SD 1.77)

11.97 (SD 1.40)

p < 0.001^a

Aflibercept intravitreal injection (n, SD)

1.51 (SD 0.33)

5.82 (SD 0.73)

7.45 (SD 1.02)

9.32 (SD 1.23)

P < 0.001^a

Ranibizumab intravitreal injection (n, SD)

4.40 (SD 0.97)

3.78 (SD 0.790)

4.97 (SD 1.22)

1.15 (SD 0.49)

p = 0.006^a

Bevacizumab intravitreal injection (n, SD)

0.30 (SD 0.113)

0.30 (SD 0.169)

0.51 (SD 0.176)

1.26 (SD 0.451)

p = 0.069^a

Dexamethasone intravitreal implant (n, SD)

0.14 (SD 0.140)

0.23 (SD 0.166)

0.14 (SD 0.083)

0.26 (SD 0.236)

p = 0.702^a